180 related articles for article (PubMed ID: 28812539)
1. Investigating Ebola virus pathogenicity using molecular dynamics.
Pappalardo M; Collu F; Macpherson J; Michaelis M; Fraternali F; Wass MN
BMC Genomics; 2017 Aug; 18(Suppl 5):566. PubMed ID: 28812539
[TBL] [Abstract][Full Text] [Related]
2. Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses.
Pappalardo M; Juliá M; Howard MJ; Rossman JS; Michaelis M; Wass MN
Sci Rep; 2016 Mar; 6():23743. PubMed ID: 27009368
[TBL] [Abstract][Full Text] [Related]
3. VP24-Karyopherin Alpha Binding Affinities Differ between Ebolavirus Species, Influencing Interferon Inhibition and VP24 Stability.
Schwarz TM; Edwards MR; Diederichs A; Alinger JB; Leung DW; Amarasinghe GK; Basler CF
J Virol; 2017 Feb; 91(4):. PubMed ID: 27974555
[TBL] [Abstract][Full Text] [Related]
4. An all-atom molecular dynamics study of the anti-interferon signaling of Ebola virus: interaction mechanisms of EBOV VP24 binding to Karyopherin alpha5.
Ding JN; Zhang YJ; Zhong H; Ao CC; Li J; Han JG
Mol Biosyst; 2017 May; 13(5):1031-1045. PubMed ID: 28418440
[TBL] [Abstract][Full Text] [Related]
5. Changes associated with Ebola virus adaptation to novel species.
Pappalardo M; Reddin IG; Cantoni D; Rossman JS; Michaelis M; Wass MN
Bioinformatics; 2017 Jul; 33(13):1911-1915. PubMed ID: 28200119
[TBL] [Abstract][Full Text] [Related]
6. Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.
Reid SP; Valmas C; Martinez O; Sanchez FM; Basler CF
J Virol; 2007 Dec; 81(24):13469-77. PubMed ID: 17928350
[TBL] [Abstract][Full Text] [Related]
7. The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold.
Zhang AP; Bornholdt ZA; Liu T; Abelson DM; Lee DE; Li S; Woods VL; Saphire EO
PLoS Pathog; 2012 Feb; 8(2):e1002550. PubMed ID: 22383882
[TBL] [Abstract][Full Text] [Related]
8. Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24.
Ramanathan P; Tigabu B; Santos RI; Ilinykh PA; Kuzmina N; Vogel OA; Thakur N; Ahmed H; Wu C; Amarasinghe GK; Basler CF; Bukreyev A
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243162
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the Ebola Virus VP24 Protein by SUMO.
Vidal S; El Motiam A; Seoane R; Preitakaite V; Bouzaher YH; Gómez-Medina S; San Martín C; Rodríguez D; Rejas MT; Baz-Martínez M; Barrio R; Sutherland JD; Rodríguez MS; Muñoz-Fontela C; Rivas C
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597768
[TBL] [Abstract][Full Text] [Related]
10. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.
Mateo M; Carbonnelle C; Reynard O; Kolesnikova L; Nemirov K; Page A; Volchkova VA; Volchkov VE
J Infect Dis; 2011 Nov; 204 Suppl 3():S1011-20. PubMed ID: 21987737
[TBL] [Abstract][Full Text] [Related]
11. The Ebola Virus Interferon Antagonist VP24 Undergoes Active Nucleocytoplasmic Trafficking.
Harrison AR; David CT; Rawlinson SM; Moseley GW
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452514
[TBL] [Abstract][Full Text] [Related]
12. Is the Bombali virus pathogenic in humans?
Martell HJ; Masterson SG; McGreig JE; Michaelis M; Wass MN
Bioinformatics; 2019 Oct; 35(19):3553-3558. PubMed ID: 31093647
[TBL] [Abstract][Full Text] [Related]
13. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24.
Kwofie SK; Broni E; Teye J; Quansah E; Issah I; Wilson MD; Miller WA; Tiburu EK; Bonney JHK
Comput Biol Med; 2019 Oct; 113():103414. PubMed ID: 31536833
[TBL] [Abstract][Full Text] [Related]
14. Importin-α7 Is Involved in the Formation of Ebola Virus Inclusion Bodies but Is Not Essential for Pathogenicity in Mice.
Gabriel G; Feldmann F; Reimer R; Thiele S; Fischer M; Hartmann E; Bader M; Ebihara H; Hoenen T; Feldmann H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S316-21. PubMed ID: 26185094
[TBL] [Abstract][Full Text] [Related]
15. Evasion of interferon responses by Ebola and Marburg viruses.
Basler CF; Amarasinghe GK
J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
[TBL] [Abstract][Full Text] [Related]
16. A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity.
Watt A; Moukambi F; Banadyga L; Groseth A; Callison J; Herwig A; Ebihara H; Feldmann H; Hoenen T
J Virol; 2014 Sep; 88(18):10511-24. PubMed ID: 24965473
[TBL] [Abstract][Full Text] [Related]
17. In Silico Study of Plant Polyphenols' Interactions with VP24-Ebola Virus Membrane-associated Protein.
Pleško S; Volk H; Lukšič M; Podlipnik Č
Acta Chim Slov; 2015; 62(3):555-64. PubMed ID: 26454589
[TBL] [Abstract][Full Text] [Related]
18. Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.
Ilinykh PA; Lubaki NM; Widen SG; Renn LA; Theisen TC; Rabin RL; Wood TG; Bukreyev A
J Virol; 2015 Aug; 89(15):7567-83. PubMed ID: 25972536
[TBL] [Abstract][Full Text] [Related]
19. Expression of the Ebola Virus VP24 Protein Compromises the Integrity of the Nuclear Envelope and Induces a Laminopathy-Like Cellular Phenotype.
Vidal S; Sánchez-Aparicio M; Seoane R; El Motiam A; Nelson EV; Bouzaher YH; Baz-Martínez M; García-Dorival I; Gonzalo S; Vázquez E; Vidal A; Muñoz-Fontela C; García-Sastre A; Rivas C
mBio; 2021 Aug; 12(4):e0097221. PubMed ID: 34225493
[TBL] [Abstract][Full Text] [Related]
20. Ebola virus VP24 interacts with NP to facilitate nucleocapsid assembly and genome packaging.
Banadyga L; Hoenen T; Ambroggio X; Dunham E; Groseth A; Ebihara H
Sci Rep; 2017 Aug; 7(1):7698. PubMed ID: 28794491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
